TLR8 and neoplasm: Additional anti-cancer mechanisms may include inhibiting Treg function by binding to TLR-8 on Treg [61] and preventing tumor-induced T cell senescence by blocking the release of cyclic adenosine monophosphate from melanoma cells [72].